iCell Gene Therapeutics
Research - Stony Brook, New York, United States
iCell Gene Therapeutics Employees
iCell Gene Therapeutics Details
iCell Gene Therapeutics is developing Chimeric Antigen Receptor (CAR) engineered cells with improved functional properties and expanded applicability. We are a clinical stage company focused to demonstrate clinical proof of concept for unique, patent protected, targets and strategies.Our pipeline includes multiple additional first in man CAR strategies to target hematological cancers, non-hematological cancers and autoimmune disorders.
Website:
http://www.icellgene.com
Employees:
2
HQ:
(631) 238-1908
Location:
Stony Brook, New York, United States
Revenue:
2M
iCell Gene Therapeutics Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
Hosting
Blue Host
Other
Mobile Friendly
Analytics and Tracking
Google Analytics